Immune globulin infusion (human) (Takeda)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameImmune globulin infusion (human) (Takeda)
Drug Alias NameGlovenin-I 10%TAK-339TAK-961
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcute BronchitisPemphigusPemphigoid, Bullous +[16] 
Global Approved IndicationsAcute BronchitisPemphigusPemphigoid, Bullous +[15] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2026/01/01
Country/TerritoryCanadaUnited StatesPoland +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBaxalta Innovations GmbhTakeda Pharmaceutical Co LtdTakeda Development Center Americas Inc
Inactive CompaniesN/A
Active IndicationsAcute BronchitisPemphigusPemphigoid, Bullous +[16] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A